PMED — Peptonic Medical AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK22.72m
- SEK15.14m
- SEK37.12m
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | Interim Report | ARS | ARS | PRESS |
Standards: | — | — | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 36 | 39.4 | 10.2 | 3.57 | 15.1 |
Net Total Receivables | 0.945 | 5.51 | 5.69 | — | 6.37 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 37.7 | 55.6 | 27.1 | 31.4 | 40.4 |
Net Property, Plant And Equipment | 0 | 1.51 | 4.2 | 4.3 | 3.78 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 92 | 111 | 83.5 | 85.8 | 107 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.24 | 16.8 | 31.5 | 35.1 | 31.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 6.24 | 16.8 | 31.5 | 38.7 | 31.4 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 85.7 | 94.5 | 52 | 47.1 | 75.3 |
Total Liabilities & Shareholders' Equity | 92 | 111 | 83.5 | 85.8 | 107 |
Total Common Shares Outstanding |